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AbstrAct
Objectives To investigate associations between maternal 
body mass index (BMI) at delivery (using pregnancy-
specific BMI cut-off values 5 kg/m2 higher in each of the 
WHO groups) and clinical, theatre utilisation and health 
economic outcomes for women undergoing caesarean 
section (CS).
Design A prospective multicentre observational study.
Setting Seven secondary or tertiary referral obstetric 
hospitals.
Participants One thousand and four hundred and fifty-
seven women undergoing all categories of CS.
Data collection Height and weight were recorded at 
the initial antenatal visit and at delivery. We analysed 
the associations between delivery BMI (continuous and 
pregnancy-specific cut-off values) and total theatre time, 
surgical time, anaesthesia time, maternal and neonatal 
adverse outcomes, total hospital admission and theatre 
costs.
Results Mean participant characteristics were: age 32 years, 
gestation at delivery 38.4 weeks and delivery BMI 32.2 kg/
m2. Fifty-five per cent of participants were overweight, obese 
or super-obese using delivery pregnancy-specific BMI cut-off 
values. As BMI increased, total theatre time, surgical time and 
anaesthesia time increased. Super-obese participants had 
approximately 27% (17 min, p<0.001) longer total theatre 
time, 20% (9 min, p<0.001), longer surgical time and 40% 
(11 min, p<0.001) longer anaesthesia time when compared 
with normal BMI participants. Increased BMI at delivery was 
associated with increased risk of maternal intensive care unit 
admission (relative risk 1.07, p=0.045), but no increased risk 
of neonatal admission to higher acuity care. Total hospital 
admission costs were 15% higher in super-obese women 
compared with normal BMI women and theatre costs were 
27% higher in super-obese women.
Conclusions Increased maternal BMI was associated 
with increased total theatre time, surgical and anaesthesia 
time, increased total hospital admission costs and theatre 
costs. Clinicians and health administrators should consider 
these clinical risks, time implications and financial costs 
when managing pregnant women.
IntroductIon
Obesity in women of childbearing age, in 
high-income counties, is a major global 
health issue. WHO uses the body mass index 
(BMI) to define categories of size in adults: 
underweight, normal, overweight, obese 
(subdivided in to class I, II) and super-
obese (class III). BMI is defined a person’s 
weight in kilograms divided by the square 
of their height in metres (kg/m2). WHO 
uses a BMI of ≥25.0–29.9 kg/m2 to define 
overweight, a BMI value of 30.0–39.9 kg/m2 
to define obesity (class I and II) and a BMI 
value of ≥40.0 kg/m2 to define super-obe-
sity (class III).1 Using these BMI categories, 
the obesity rate in women of childbearing 
age has increased in high-income countries 
from 16% in 1993 to 24% in 2007.2
In pregnancy, an increased BMI is asso-
ciated with adverse pregnancy outcomes 
including venous thromboembolism, 
pre-eclampsia, postpartum haemorrhage 
and maternal death.2–6 During pregnancy, 
both prepregnancy BMI and BMI changes 
that occur as the result of gestational weight 
gain contribute to the BMI at delivery. 
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Strengths and limitations of this study
 ► Large multicentre prospective study.
 ► Broad representation of hospitals: two tertiary 
maternity, two urban general, three regional/rural.
 ► First prospective study examining associations 
between body mass index and clinical, time and 
economic outcomes.
 ► All women undergoing caesarean section included.
 ► We were not able to determine the cause of the 
increased time.
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When considering BMI at delivery the use of non-preg-
nant BMI categories leads to over-representation of 
overweight or obese women in studies undermining 
analysis of the risks of obesity.7 These limitations in 
using non-pregnant metrics at delivery has prompted 
groups to suggest that pregnancy-specific BMI cut-off 
values be considered with a BMI of 35 kg/m2 or 
greater as a threshold for obesity at delivery rather 
than ≥30 kg/m2.8 Following on from defining delivery 
obesity (class I and II) as a BMI of ≥35 kg/m2, a logical 
extension is to define delivery super-obesity (class III) 
as a BMI ≥45 kg/m2.
Regardless of problems in formally defining obesity 
at delivery, the rates of obesity in pregnancy are 
increasing, with the rate of prepregnancy obesity 
increasing, and the rates of women gaining exces-
sive gestational weight during pregnancy increasing.9 
Coupled with this are increasing caesarean section 
rates, especially in women with increased BMI ≥25.0 kg/
m2.3 10 When combined with increasing maternal size, 
the risks associated with caesarean section may be 
increased leading to adverse maternal and neonatal 
outcomes, increased total theatre times and increased 
hospital costs. While there is considerable literature 
about obesity during pregnancy and postdelivery 
outcomes,3 there are fewer reports on the relation-
ship between obesity and time it takes to perform a 
caesarean section and hospital costs in this setting. 
One small (n=100) single-centre retrospective study 
from the USA suggested that total theatre times were 
increased for women undergoing caesarean section 
with BMI ≥40 kg/m2 compared with women with a 
lower BMI.11 While clinicians have greater experience 
in safely caring for obese and super-obese women, 
anecdotal reports indicate that increased duration of 
caesarean section for obese women adversely affects 
operating theatre suite planning and theatre utilisa-
tion, and may have resource implications. There are, 
however, no quantitative data on these effects.
The aim of this study was to investigate the association 
between maternal size at delivery using pregnancy-spe-
cific BMI cut-off values and clinical (maternal and 
neonatal), theatre utilisation and health economic 
outcomes for women undergoing caesarean section. 
We aimed to determine if pregnancy-specific BMI 
cut-off values of 35 kg/m2 for obesity and 45 kg/m2 
for super-obesity are appropriate to assist planning 
around the time of delivery including resource alloca-
tion and theatre scheduling. Our primary hypothesis 
was that maternal obesity is associated with increased 
total theatre time. Our secondary hypotheses were that 
maternal obesity is associated with increased anaes-
thesia time, increased surgical time, increased length of 
hospital stay, increased use of intensive care services for 
women and neonatal services for babies and increased 
hospital costs.
Methods
study participants
A prospective multicentre observational study was 
performed in collaboration with the seven obstetric 
teaching hospitals affiliated with the University of 
Melbourne: two city tertiary maternity, two outer 
urban general and three regional and rural. The study 
protocol was approved through the centralised ethics 
approval process (see online supplementary appendix 
1) with individual hospital site-specific approvals. 
The study was registered with the Australian Clin-
ical Trial Registry prior to participant recruitment 
(ACTRN1261300060876; Universal Trial Number: 
U1111-1143-2500). The study was conducted in accor-
dance with ICH GCP notes for Guidance on Good 
Clinical Practice (CPMP/ICH/135/95). The study 
was conducted during a 14-month period from 23 
November 2013 to 2 February 2015 during which time 
consecutive women were recruited at each of the seven 
hospitals over at least a 3-month period.
Consecutive women undergoing caesarean section, 
elective and emergency, were eligible if they were aged 
18 years or older. Women were not eligible if they 
were aged <18 years; undergoing planned combined 
surgery, for example, caesarean and tubal ligation; or 
the woman requested her data were excluded or either 
parent requested the baby’s data were excluded. Once 
eligible participants were identified and included in 
the study, at a clinically appropriate time (before, 
during or after delivery), a doctor or trial coordinator 
sought verbal consent from eligible women using a 
standardised script approved by the Ethics Committee. 
A case report form (CRF) was developed to record 
maternal, neonatal, anaesthesia and surgical details and 
maternal and neonatal outcomes. Data were recorded 
in the CRF and entered into the REDCap web-based 
data system (Vanderbilt University, USA) hosted at the 
University of Melbourne. Management of anaesthesia, 
surgery and postdelivery care was at the discretion of 
the clinical team.
Maternal BMI
Maternal BMI at booking and delivery was calculated. 
Booking BMI was derived using the recorded weight 
at the first antenatal appointment, if available, while 
delivery BMI used the recorded weight and height at 
the time of the caesarean section. Delivery BMI was 
grouped into BMI categories of underweight, normal, 
overweight, obese and super-obese using standard 
WHO cut-off values (<18.5 kg/m2 underweight, 18.5 to 
<25 kg/m2 normal, 25 to <30 kg/m2 overweight, 30 to 
<40 kg/m2 obese (class I and II), ≥40kg/m2 super-obese 
(class III)) and also pregnancy-specific cut-off values for 
women at delivery: WHO+5 kg/m2 (<23.5 kg/m2 under-
weight, 23.5 to <30 kg/m2 normal, 30 to <35 kg/m2 
overweight, 35 to <45 kg/m2 obese, ≥45 kg/m2 super-
obese).
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classification of urgency of caesarean section
Urgency of caesarean section was defined using Royal 
College of Obstetricians and Gynaecologists United 
Kingdom definitions.*12
total theatre time, surgical time and anaesthesia time
Total theatre time (min) was defined using the Austra-
lian Federal Department of Health and Aging definition 
of total anaesthesia time: from when the anaesthe-
tist commenced exclusive and continuous care of the 
patient for anaesthesia until when the anaesthetist was 
no longer in professional attendance, that is, when the 
participant was safely placed under the supervision of 
other personnel, usually recovery nursing staff.13 Start 
time and finish time were recorded. Surgical time was 
defined as the time from the start of abdominal prep-
ping until the time the final dressing was applied to the 
surgical wound. Anaesthesia time was defined as total 
theatre time-surgical time. This time was when only 
anaesthesia was being performed and not when anaes-
thesia and surgery were being undertaken together. 
The end of the operative day was defined as the next 
midnight following arrival in the postanaesthesia care 
unit.
health economic data and cost analysis
Individual cost data of the study participants from the 
two largest recruiting centres centres, a specialist centre 
and an outer urban hospital, were used for the economic 
analysis and were representative of the type and locality 
of hospitals in Australia.14 Hospitalisation costs rele-
vant to each participant’s admission for caesarean 
delivery were extracted from participants’ hospital 
records retrospectively. Costs, in Australian dollars 
($AUD), obtained were based on each participant’s 
hospital resource use, categorised into relevant-spe-
cific subgroups for the entire length of their admission. 
Total hospital admission cost was the sum of three cost 
subgroups such that total hospital admission cost=the-
atre cost+surgical service cost+inpatient cost. The three 
groups were defined as follows: theatre costs were the 
total cost of the use of operating room, supplies and 
staff (both anaesthetist and surgical teams) necessary 
to perform the caesarean section, surgical service costs 
were the costs pertaining to the surgical supplies and 
staff (surgeon’s time) only and inpatient costs were 
composed of all other costs associated with the hospital 
admission such as nursing, medical imaging, pathology, 
allied and pharmacy.
Cost subgroup specifications between the two hospi-
tals were compared, and where necessary, regrouped 
to ensure comparability. From the two hospitals, to 
*Category 1 = maternal or fetal compromise H immediate threat to life 
of woman or fetus; Category 2 = maternal or fetal compromise H no 
immediate threat to life of woman or fetus; Category 3 = no maternal 
or fetal compromise – requires early delivery; Category 4 = no maternal 
or fetal compromise – delivery at a time to suit woman and maternity 
services
quantify theatre costs and surgical service costs per 
minute, costs from the theatre and surgical service 
subgroups were divided by the total theatre times and 
surgical times, respectively. National costs were esti-
mated to 2020 assuming linear progression based on 
historical data on number of pregnancies and propor-
tions of caesarean sections and obesity among pregnant 
women. Costs were discounted at a standard rate of 5% 
adjusting future costs to reflect present value.15 16
statistical analysis
Over a 3-month period, we expected that about 1500 
women would undergo caesarean section at the seven 
participating hospitals. We estimated that between a 
quarter (n=375) to a third (n=500) of those women 
would be obese at delivery with a pregnancy-spe-
cific cut-off BMI ≥35 kg/m2 and about 5% (n=75) to 
have a BMI ≥45 kg/m2. Therefore, this study would 
have approximately 80% power to detect a difference 
of 0.17 hours (~10 min) in the average theatre time 
between non-obese and obese participants, assuming 
α=0.05 and approximately 80% power to detect a differ-
ence of 0.33 hours (~20 min) between those ≥45 kg/m2 
and those <35 kg/m2. These defined BMI classes were 
part of our secondary end analyses; our primary analysis 
was to treat BMI as a continuous variable. The nature of 
the continuous relationship between BMI and time was 
unclear so we did not perform a sample size calculation 
on the primary analysis.
Linear regression was used to examine associations 
between continuous delivery BMI and total theatre 
time. To determine if maternal obesity was associated 
with increased total theatre time, we considered catego-
ries of BMI (underweight <23.5 kg/m2, normal weight 
23.5 to <30 kg/m2, overweight 30 to <35 kg/m2, obese 
to <45 kg/m2, super-obese ≥45 kg/m2) as a predictor of 
total theatre time in linear regression models. To assess 
the assumptions that the residuals are normally distrib-
uted with zero mean and constant variance, normality 
plots and plots of residuals against fitted values will be 
examined. All models include adjustment for hospital. 
We used these BMI classifications as underweight, 
normal weight, overweight, obese and super-obese 
rather than the usual non-pregnant cut-off points that 
are 5 kg/m2 lower because our variable of interest was 
BMI at delivery. Both unadjusted analyses and anal-
yses adjusted for potential confounders (age (years), 
delivery gestation (weeks), multiple pregnancy (no/
yes), pre-eclampsia (no/yes), caesarean section urgency 
(category 1, category 2, category 3, category 4), previous 
caesarean section (no/yes), delivery hospital). Bonfer-
roni-adjusted multiple comparisons were conducted 
to identify where there was evidence of a difference 
between BMI classifications. We conducted a complete 
case analysis, omitting participants who were missing 
data on the outcome or exposure variable, or any of 
the confounding variables. We conducted secondary 
analysis of surgery time and anaesthesia time using the 
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Table 1 Demographic and obstetric data
Characteristics
Mean (SD) and 
range/n (%)
Age (years)† 32.0 (5.2) 18.0–50.0
Gestation at booking visit (weeks) 17.0 (6.2) 1.0–39.0
Weight at booking visit (kg) 75.0 (20.2) 35.0–158.0
BMI at booking visit (kg/m²) 28.0 (7.0) 15.8–62.3
Gestation at delivery (weeks) 38.0 (2.1) 25.0–42.0
BMI at caesarean section (kg/m²) 32.0 (6.9) 17.0–66.2
Difference in BMI between delivery 
and booking visit (kg/m2)
4.0 (2.7) −3.6–16.9
Comorbidities
  Previous caesarean section 638 (43.8%)
  Multiple pregnancy 68 (4.7%)
  Pre-eclampsia 62 (4.3%)
Classification of urgency of 
caesarean section*
  Category 1 116 (8.0%)
  Category 2 433 (29.7%)
  Category 3 261 (17.9%)
  Category 4 647 (44.4%)
Maternal and neonatal outcomes
  Mother admitted to intensive 
care unit
11 (0.7%)
  Mother received red cell 
transfusion
20 (1.4%)
  Mother returned to the operating 
room
9 (0.6%)
  Neonate admitted to neonatal 
intensive care unit
60 (4.1%)
  Neonate admitted to special care 
unit
227 (15.6%)
*Royal College of Obstetricians and Gynaecologists (RCOG) 
classification.
†Age at delivery. 
‡Sample from 1505 participants excluding those missing data 
on duration of anaesthesia (n=1; 0.1%), BMI (n=45; 3.0%) and 
potential confounders: age (n=1; 0.1%), gestation at delivery 
(no missing), multiple pregnancy (n=1; 0.1%), pre-eclampsia (no 
missing), caesarean section urgency (n=3; 0.2%) and previous 
caesarean section (no missing); n=1457.
BMI, body mass index.
same approach as described for the total theatre time. 
Unadjusted log-binomial regression models were fitted 
to determine whether there was an association between 
delivery BMI (BMI at delivery) and the risk of infant 
admission to a neonatal intensive care unit (NICU) or 
special care nursery, or the risk of a maternal admis-
sion to intensive care unit, readmission to the operating 
room or red cell transfusion. In these analyses, only 
three categories of BMI (underweight and normal, 
overweight, obese and super-obese) were considered 
due to the small number of cases for some outcomes. 
For health economic data, all mean costs of hospital 
resource use were reported with SDs or 95% CIs; t-test 
was used to test for mean differences for each BMI 
categories against the normal group and their p values 
reported. Linear regression was performed to quan-
tify the relationship between BMI and hospitalisation 
cost. All statistical analysis was conducted using Stata 
V.13.0. This study is reported using the Strengthening 
the reporting of observational studies in epidemiology 
(STROBE) guidelines.17
results
study participants
At the seven hospitals, during the data collection 
periods, there were a total of 1978 caesarean section 
operations; a total of 1505 (76%) women consented to 
participate. The primary end point of total theatre time 
was not recorded by the responsible anaesthetist in 48 
participants and we did not attempt to retrospectively 
determine the total theatre time. Therefore, the final 
sample size was 1457 participants. We were unable to 
obtain maternal delivery weights for 3% of those who 
consented to take part. The demographic and obstetric 
characteristics and clinical outcomes of the partici-
pants are shown in table 1. Thirty-eight per cent of 
the caesarean sections were from the two categories of 
greatest urgency (categories 1 and 2). General anaes-
thesia was the initial anaesthesia type in 39 women with 
similar proportions of women in each BMI category 
undergoing general anaesthesia (2.4%, 3.8%, 2.0%, 
2.5% in normal, overweight, obese and super-obese 
categories, respectively, p=0.394).
Maternal BMI
The average BMI at delivery (table 1, figure 1) was 
32 kg/m2, ranging from 17 to 66 kg/m2 with 312 (21%) 
women weighing >100 kg. With the pregnancy-spe-
cific cut-off points for women at delivery, normal BMI 
was defined as being 23.5 to <30 kg/m2; this 5 kg/
m2 increase on the usual range is consistent with our 
finding of a mean BMI increase of 4.0 kg/m2 from 
booking (mean 17 weeks gestation) to delivery. Using 
usual WHO BMI criteria, 88% of the participants would 
have been classified as overweight, obese or super-
obese (figure 1). Using the modified BMI criteria, this 
fell to 55% of pregnant women being overweight, obese 
or super-obese, consistent with Australian population 
norms.18 For category 1 caesarean sections, where there 
is an immediate risk to maternal or fetal life, 54 women 
(3.7% of total group) were classified as overweight, 
obese or super-obese according to pregnancy-specific 
cut-off values for women at delivery (table 2). The inci-
dence of pre-eclampsia ranged from 3% in normal BMI 
to 14% in the super-obese.
total theatre time
The average total theatre time for caesarean section was 
76 min (SD 19.3, range 34–165 min). We found a positive 
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Figure 1 Frequency of body mass index categories 
according to WHO and proposed pregnancy classifications 
WHO cut-off points: <18.5 kg/m2 underweight; 18.5 to <25 kg/
m2 normal; 25 to <30 kg/m2 overweight; 30 to <40 kg/m2 
obese; ≥40 kg/m2 super-obese. Proposed pregnancy cut-off 
points: <23.5 kg/m2 underweight; 23.5 to <30 kg/m2 normal; 
30 to <35 kg/m2 overweight; 35 to <45 kg/m2 obese; ≥45 kg/
m2 super-obese.
Table 2 Descriptive characteristics of the participants by pregnancy proposed BMI category
Underweight Normal weight Overweight Obese Super-obese
Mean (SD) and range/n (%) n=79 n=570 n=395 n=337 n=76
Total theatre time (min) 69 (18.7)
34.0–120.0
72 (17.4)
36.0–156.0
77 (17.9)
35.0–150.0
80 (20.1)
40.0–165.0
92 (23.5)
49.0–157.0
Surgical time (min) 44 (13.2)
23.0–75.0
45 (13.9) 20.0–
126.0
48 (14.4) 
20.0–115.0
50 (14.8) 
20.0–115.0
54 (15.1) 
32.0–111.0
Anaesthesia time (min) 26 (11.2) 
9.0–50.0
27 (10.8) 5.0–
104.0
28 (11.3) 
0.0–84.0
29 (12.3) 
3.0–113.0
38 (17.9) 
0.0–107.0
BMI at delivery (kg/m2) 22 (1.5)
17.0–23.4
27 (1.8)
23.5–30.0
32 (1.4)
30.0–34.9
39 (2.9)
35.0–45.0
50 (4.4)
45.1–66.2
Age at delivery (years) 30 (4.7)
20.0–43.3
32 (5.1)
18.0–50.0
32 (5.0)
19.0–48.0
32 (5.5)
19.0–46.0
31 (5.5)
20.0–44.0
Gestation at delivery (weeks) 38 (2.7)
25.0–41.0
39 (2.2)
25.0–42.0
39 (1.9)
26.0–42.0
39 (2.0)
27.0–42.0
38 (2.0)
31.0–40.0
Multiple pregnancy 4 (5.1%) 33 (5.8%) 18 (4.6%) 11 (3.3%) 2 (2.6%)
Pre-eclampsia 0 (0.0%) 16 (2.8%) 18 (4.6%) 17 (5.0%) 11 (14.5%)
Caesarean section urgency*
  Category 1 4 (5.1%) 58 (10.2%) 27 (6.8%) 26 (7.7%) 1 (1.3%)
  Category 2 27 (34.2%) 171 (30.0%) 116 (29.4%) 101 (30.0%) 18 (23.7%)
  Category 3 16 (20.3%) 91 (16.0%) 73 (18.5%) 63 (18.7%) 18 (23.7%)
  Category 4 32 (40.5%) 250 (43.9%) 179 (45.3%) 147 (43.6%) 39 (51.3%)
  Previous caesarean section 33 (41.8%) 226 (39.7%) 168 (42.5%) 174 (51.6%) 37 (48.7%)
Mother admitted to ICU 0 (0.0%) 1 (0.2%) 4 (1.0%) 5 (1.5%) 1 (1.3%)
Mother received transfusion 1 (5.0%) 4 (20.0%) 10 (50.0%) 5 (25.0%)  0 (0.0%)
Mother returned to OR 1 (11.1%) 4 (44.4%) 2 (22.2%)  2 (22.2%)  0 (0.0%)
NICU 4 (5.1%) 28 (4.9%) 15 (3.8%) 10 (3.0%) 3 (3.9%)
Special care 16 (20.3%) 82 (14.4%) 50 (12.7%)  65 (19.3%) 14 (18.4%)
*Percentages are calculated from the the number of women in each caesarean section per total number of women in BMI category.
BMI, body mass index; ICU, intensive care unit; NICU, neonatal intensive care unit.
association between BMI at delivery and total theatre 
time: for every 1 kg/m2 increase in BMI, total theatre time 
increased, on average, by 0.6 min (95% CI 0.51 to 0.77). 
Using pregnancy-specific BMI categories for women 
at delivery, the mean total theatre time increased with 
increasing BMI category (table 2 and figure 2). Women 
classed as obese at delivery had a mean increase in total 
theatre time of 7.7 min (10%) compared with those 
classed as normal BMI, while women classed as super-
obese at delivery had a total theatre time 19.8 min (26%) 
longer than those who were of normal BMI (table 3 and 
figure 2). Both surgical and anaesthesia time increased 
in a linear fashion with BMI: for every 1 kg/m2 increase 
in BMI, surgical time increased on average by 0.3 min 
(95% CI 0.23 to 0.44) and anaesthesia time by 0.3 min 
(95% CI 0.22 to 0.39). However, considering the preg-
nancy BMI thresholds, there was a marked increase in 
the mean anaesthesia time between the obese and super-
obese groups (mean increase of 8.4 min, 95% CI 4.38 to 
12.38), which was not the case for the mean surgery time 
(mean increase of 3.3 min, 95% CI −1.66 to 8.26).
Maternal and neonatal outcomes
No mother or neonate died within 5 days of delivery. 
While numbers were small, there was some evidence that 
group.bmj.com on October 8, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
6 Dennis AT, et al. BMJ Open 2017;7:e015630. doi:10.1136/bmjopen-2016-015630
Open Access 
Figure 2 Anaesthesia alone, surgical and total operating room times (mean and SD) by delivery BMI category. BMI, body mass 
index. 
Table 3 Mean time differences by body mass index 
category compared with normal body mass index
Paired comparison
Difference mins 
(95% CI)* p Value
Total theatre time
  Normal—underweight 2.7 (−3.6 to 9.0) 1.000
  Overweight—normal 4.7 (1.3 to 8.2) 0.001
  Obese—normal 7.7 (4.1 to 11.3) <0.001
  Super-obese—normal 19.8 (13.4 to 26.2) <0.001
Surgical time
  Normal—underweight 1.6 (−3.2 to 6.4) 1.000
  Overweight—normal 2.9 (0.3 to 5.6) 0.017
  Obese—normal 4.9 (2.2 to 7.7) <0.001
  Super-obese—normal 8.7 (3.8 to 13.7) <0.001
Anaesthesia time
  Normal—underweight 1.1 (−2.9 to 5.1) 1.000
  Overweight—normal 1.8 (−0.38 to 3.95) 0.207
  Obese—normal 2.8 (0.5 to 5.1) 0.006
  Super-obese—normal 11.1 (7.0 to 15.1) <0.001
*Bonferroni adjusted.
greater BMI was associated with increased maternal admis-
sion to ICU (relative risk (RR) 1.07, 95% CI 1.00 to 1.14; 
p=0.045). Of 11 women (0.7%) admitted to ICU after 
delivery (table 2), 6 were obese or super-obese (54.5%) 
compared with 1 in the normal weight or underweight 
group (9.1%) (overweight/obese vs normal/under-
weight RR 1.55, 95% CI: −0.04 to 3.15; p=0.057). There 
was no evidence of an difference between receiving a red 
cell transfusion or return to the operating room between 
those who were classified as obese/super-obese and those 
who were normal or underweight (red cell transfusion: 
overweight/obese vs normal/underweight RR 1.57, 
95% CI 0.46 to 5.39; p=0.47; return to operating room: 
overweight/obese vs normal/underweight RR 0.63, 
95% CI 0.12 to 3.22; p=0.58). Furthermore, we did not 
find evidence of an association between delivery BMI and 
increased admission to NICU. Overall 60 neonates (4.1%) 
were admitted to NICU. Of these, 13 were the babies of 
obese or super-obese women (21.7%) compared with 32 in 
the normal weight or underweight group (53.3%) (over-
weight/obese vs normal/underweight RR 0.64, 95% CI 
0.34 to 1.20; p=0.16). Overall, 227 neonates (15.6%) were 
admitted to special care. Of these, 79 were the babies of 
obese or super-obese women (34.8%) compared with 82 
in the normal or underweight BMI group (43.2%) (over-
weight/obese vs normal weight/underweight RR 1.26, 
95% CI 0.96 to 1.65; p=0.09).
economic outcomes
We performed the economic analysis on 768 participants 
from one of the specialist obstetric hospitals (325) and 
one of the outer urban hospitals (443); 53% of the total 
study sample. With the exception of women who were 
underweight at delivery, women with above normal BMI 
incurred higher total hospital admission cost (table 4). 
The mean total hospital admission cost for a woman 
of normal BMI was $AUD7359 (SD, $AUD3039) while 
women in the super-obese category had total costs of 
$AUD8488 (SD, $AUD3564) (table 4), which translates to 
a 15% increase in total hospital admission costs between a 
normal BMI and super-obese women of $AUD1129 (95% 
CI $AUD95 to $AUD2163). Approximately three-quar-
ters of the total hospital admission cost was attributable 
to inpatient costs including nursing, medications and all 
other resources used during the patient’s hospital stay 
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Table 4 Mean costs and hospital length of stay, across BMI categories.
N
BMI categories
Underweight Normal Overweight Obese Super-obese
52 320 192 165 39
Total hospital admission costs,
  Mean ($AUD) 7605 7359 7442 7530 8487
  SD 3589 3039 2543 2680 3564
Cost subgroups
  Theatre, mean ($AUD) 2531 2306 2466 2556 2814
  SD 1788 724 836 795 1103
Length of hospital stay
  Mean (days) 3.8 4.0 4.0 3.9 4.4
  Min-max (days) 1–11 1–15 1–20 1–14 3–9
BMI, body mass index.
while theatre costs accounted for a quarter of the total 
cost (table 4). The approximate average theatre cost 
per minute for women undergoing caesarean section in 
general, regardless of BMI, was $AUD35/min.
Mean theatre cost increased progressively as BMI 
increased; there was evidence of a difference in cost 
between each of the higher BMI categories compared 
with women with normal BMI. Compared with normal 
BMI women, theatre costs were increased by 7% in the 
overweight, 11% in the obese and 22% in super-obese 
women. Women who were classified as super-obese 
incurred the greatest cost in all the other subgroups, 
except for imaging, when compared with women in other 
BMI categories with costs related to pathology services 
being 55% greater than normal BMI women. The mean 
length of hospital stay was the longest for a super-obese 
patient: 4.4 days (95% CI 3.82 to 4.90); however, the 
differences between each of the BMI categories were 
small (p=0.18 for normal vs super-obese; 95% CI of the 
mean difference: −0.96 to 0.18) (table 4).
dIscussIon
We conducted a prospective multicentre study of the 
relationship between maternal BMI and outcomes 
for caesarean section. The major findings were that 
increased BMI was associated with increased total theatre 
time, increased surgical time, increased anaesthesia 
time, increased risks of maternal admission to ICU, 
increased total hospital admission costs and increased 
theatre costs. Using our predetermined pregnancy-spe-
cific cut-off values for BMI (WHO classes+5 kg/m2) for 
women at the time of delivery, we found that approx-
imately 1 in 20 women were super-obese at delivery, 
and had more than 25% longer total theatre time, 20% 
longer surgical time and 40% longer anaesthesia time, 
compared with normal weight women. Super-obese 
women also had a 15% increase in total hospital admis-
sion costs and a nearly 30% theatre costs compared with 
normal BMI women. These findings have important 
implications for understanding clinical care, operating 
theatre use and health service costs, for both clini-
cians and health services managing pregnant women. 
These clinical and cost findings support arguments for 
increased allocated theatre time and increased funding 
for care of super-obese pregnant women.
While the recording of prepregnancy BMI and gesta-
tional weight gain are important, our study supports 
routinely recording height and weight measurements 
throughout pregnancy so that BMI can be used as part 
of care planning around the time of delivery with preg-
nancy-specific BMI ranges 5.0 kg/m2 greater than the 
current WHO ranges. While we found that the average 
BMI increase during pregnancy was 4.0 kg/m2, it was 
most likely >4.0 kg/m2 due to the late average booking 
gestation of 17 weeks, leading to the pragmatic use of 
5.0 kg/m2 incremental changes in BMI classes.
We found that total hospital admission costs increased 
by 15% (about $AUD1129 per woman), including 
theatre costs by 22% (about $AUD500) in super-obese 
women compared with normal BMI women. These 
findings support the argument for increased funding 
of super-obese pregnant women. Based on our data, 
and using conservative estimates, additional hospital 
resources to manage super-obesity for Australian 
women undergoing caesarean section currently exceeds 
$AUD3.8 million annually and will continue to rise to 
over $AUD5 million per year by 2020 with cumulative 
costs of over $AUD50 million over the next 10 years.
A limitation is that we were not able to determine the 
underlying causes of the increased total theatre time, 
surgical time and anaesthesia time. The current associa-
tion between anaesthesia difficulty and maternal obesity 
is unclear. Two recent studies could not clearly associate 
maternal obesity with anaesthetic difficulty.8 19 In 2009, 
Bamgbade et al conducted a single-centre study of 1477 
women having caesarean section in the UK.19 They 
found no evidence of an association between obesity 
and increased difficulty in spinal anaesthesia, increased 
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block failure or increased use of general anaesthesia. 
This study may have been limited by using a delivery 
obesity definition of ≥30 kg/m2, which was potentially 
overinclusive. These authors speculated that a BMI 
of 35 kg/m2 (that we used) may be better to define 
obesity at delivery. In another 2009 single-centre study 
of 427 women, Ellinas et al found evidence to demon-
strate that obesity was associated with difficulty with 
neuraxial blockade for labour.8 They did, however, find 
that obesity was associated with the two factors associ-
ated with difficult neuraxial block: inability to palpate 
landmarks and limited patient flexion. In a recent 
multicentre Australian study, McDonnell et al did not 
find that general anaesthesia for caesarean section was 
more likely for patients weighing >100 kg; they did not, 
however, consider BMI.20 Similarly, in a single-centre 
study Kinsella did not find evidence of an association 
between increased maternal weight and anaesthetic 
difficulty during caesarean section.21
It is also important to note that some anaesthesia times 
were recorded as zero minutes. This occurred when 
surgical prepping and anaesthesia commenced at the same 
time. Additionally according to our definition of anaes-
thesia time, in some cases this may not reflect the total time 
to establish anaesthesia if there is a delay between surgical 
prepping and incision time due to establishment of anaes-
thesia.
An older single-centre retrospective study of predom-
inantly African-American women from the USA found 
that maternal obesity, defined as BMI >30 kg/m2, was one 
of the several factors associated with increased opera-
tive time for caesarean delivery.22 They did not examine 
anaesthetic factors nor did they examine how total time 
varied with increasing body size. Because anaesthetists, 
and the rest of the delivery team, are caring for more 
women who are obese, there is growing expertise, and 
possibly efficiency, in managing obese pregnant women. 
Added to this growing experience and expertise are 
new technologies such as use of ultrasound to guide 
neuraxial blockade23 24 and video-laryngoscopes to aid 
difficult intubation.25 The combined effect of greater 
experience and new technologies may to some extent 
counteract challenges of maternal obesity.
While we were primarily looking at overweight and 
obesity, we noted that women who were underweight had 
higher average costs and theatre times than those classi-
fied as normal weight. Mungo et al, in a study investigating 
outcomes of pulmonary resection for lung cancer, also 
found that underweight adults had a greater risk-adjusted 
length of stage compared with normal weight patients.26 
Our findings may be explained by the presence of 
maternal comorbidities. Therefore, further research is 
required to confirm this unexpected finding.
conclusIons
Pregnancy-specific BMI cut-off values for women at 
delivery are justified and enable correct classification 
of maternal size at delivery. Obesity is common among 
Australian women of childbearing age and was found to 
be associated with increased total theatre time, surgical 
and anaesthesia time, increased maternal risk of ICU 
admission, increased total hospital admission costs and 
theatre costs. There was no evidence that mothers who 
were obese had increased risk of blood transfusion, re-ad-
mission to the operating room, neonatal admission to 
higher acuity care or neonatal admission to special care 
nursery compared with those of normal weight. Clini-
cians and health administrators need to consider these 
clinical risks, the time implications and financial costs 
when managing pregnant women. To do so, we need to 
record maternal BMI during the antenatal period and 
at delivery, increase communication between clinical 
teams and increase funding for women with increased 
BMI.
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